Nav: Home

World-first human Hendra virus clinical trials begin

March 31, 2015

An antibody manufactured at The University of Queensland will be used in world-first human Hendra virus clinical trials starting this month.

UQ Australian Institute for Bioengineering and Nanotechnology (AIBN) Director Professor Peter Gray said the monoclonal antibody m.102.4 was the world's first antibody administered to humans as a treatment for the rare but deadly viral disease.

"Queensland Health contracted us to manufacture the antibody for emergency stockpiles and for the human trials," Professor Gray said.

He said the antibody was engineered to mimic antibodies the human body produced naturally as an immune system response to germs, viruses and other invaders.

"It is important to understand that the antibody treatment is not a vaccine, and it needs to be administered within a short time after exposure to the Hendra virus," he said.

The treatment is considered an experimental therapy and will only be used in emergency situations until the human trials have been completed.

There have been 52 recorded incidents of Hendra virus in horses in Australia since 1994, with 14 in New South Wales and 38 in Queensland. Ninety horses have died from the virus.

There have been seven human cases of Hendra (including four fatalities) recorded in Australia, all in Queensland.

Professor Gray said the AIBN had developed a method of producing larger amounts of the antibody without needing to reproduce any part of the Hendra virus.

The institute has produced the antibody for collaborators at the CSIRO Australian Animal Health Laboratory in Geelong for testing in animal trials.

Professor Gray said the antibody was developed through a long-standing association between Australian researchers and the US laboratories of Professor Christopher Broder at the Uniformed Services University of the Health Sciences and Dr Dimiter Dimitrov of the National Cancer Institute, National Institute of Health.

"The US laboratories were able to synthetically produce a portion of the virus and create an antibody that specifically recognised it," Professor Gray said.
-end-
View Queensland Health's media release here.

Media: Margaret Puls, AIBN Communications, 0419 578 356 or m.puls@uq.edu.au. Bottom image caption: Professor Peter Gray.

University of Queensland

Related Virus Articles:

A new biosensor for the COVID-19 virus
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus.
How at risk are you of getting a virus on an airplane?
New 'CALM' model on passenger movement developed using Frontera supercomputer.
Virus multiplication in 3D
Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies.
How the Zika virus can spread
The spread of infectious diseases such as Zika depends on many different factors.
Fighting the herpes virus
New insights into preventing herpes infections have been published in Nature Communications.
Strategies of a honey bee virus
Heidelberg, 23 October 2019 - The Israeli Acute Paralysis Virus is a pathogen that affects honey bees and has been linked to Colony Collapse Disorder, a key factor in decimating the bee population.
Tracking the HI virus
A European research team led by Prof. Christian Eggeling from the Friedrich Schiller University Jena, the Leibniz Institute of Photonic Technology (Leibniz IPHT), and the University of Oxford has now succeeded in using high-resolution imaging to make visible to the millisecond how the HI virus spreads between living cells and which molecules it requires for this purpose.
Prior Zika virus or dengue virus infection does not affect secondary infections in monkeys
Previous infection with either Zika virus or dengue virus has no apparent effect on the clinical course of subsequent infection with the other virus, according to a study published August 1 in the open-access journal PLOS Pathogens by David O'Connor of the University of Wisconsin-Madison, and colleagues.
Smartphone virus scanner is not what you think
The current leading method to assess the presence of viruses and other biological markers of disease is effective but large and expensive.
Early dengue virus infection could "defuse" zika virus
The Zika virus outbreak in Latin America has affected over 60 million people up to now.
More Virus News and Virus Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.